IFNA1 and COVID-19: Next, we evaluated whether GC cumulative dosage was correlated with GC–IFN synergistic effects on COVID-19 recovery, when IFN therapy was used in fixed dose and duration according to the guideline.28 We reasoned that true therapeutic synergy would be timing- and dose-dependent while synergy confounded by clinical indications of GC use would not.